United States · FDA National Drug Code directory
Agrylin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54092-063_80829f8c-c5ee-4e37-b5af-1b0e4e4dd5bd
- Product NDC
- 54092-063
- Form
- CAPSULE
- Composition / generic term
- anagrelide hydrochloride
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19970314
- Source listing expiry
- 20271231
Source-listed ingredients
- ANAGRELIDE HYDROCHLORIDE ANHYDROUS — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (54092-063-01) · 54092-063-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →